Low-dose computed tomography screening reduces lung cancer mortality

Area of Science:

• Oncology
• Public Health
• Radiology

Background:

• Lung cancer is the leading cause of cancer death globally, with high mortality rates often due to late diagnosis.
• Current five-year survival rates are low (12% for men, 7% for women), underscoring the need for early detection and effective prevention strategies like smoking cessation and screening.

Purpose of the Study:

• To evaluate the effectiveness of lung cancer screening programs in reducing mortality.
• To support the implementation of cost-effective screening initiatives for high-risk populations.

Main Methods:

• The National Lung Screening Trial (NLST), a large randomized clinical trial, compared low-dose computed tomography (LDCT) screening with conventional chest X-ray.
• Analysis focused on mortality reduction in participants undergoing LDCT screening.

Main Results:

• Low-dose computed tomography (LDCT) screening demonstrated a 20% reduction in lung cancer mortality compared to chest X-ray.
• These findings led to the establishment of lung cancer screening programs in the USA and China for high-risk individuals.

Conclusions:

• Lung cancer screening, particularly with LDCT, is effective in reducing mortality among high-risk populations.
• Further research into risk assessment scores and molecular markers is recommended to enhance screening effectiveness and cost-efficiency.